Stay Ahead in Fast-Growing Economies.
Browse Reports Now
Transdermal Skin Patches Market – Comprehensive Study Report & Recent Trends
Transdermal Skin Patches Market Size Was Valued at USD 7.89 Billion in 2023, and is Projected to Reach USD 12.35 Billion by 2032, Growing at a CAGR of 5.1% From 2024-2032.
IMR Group
Description
Transdermal Skin Patches Market Synopsis:
Transdermal Skin Patches Market Size Was Valued at USD 7.89 Billion in 2023, and is Projected to Reach USD 12.35 Billion by 2032, Growing at a CAGR of 5.1% From 2024-2032.
The Transdermal Skin Patches Market is centred on the processes of invention and supply of stickers that are stuck on the skin to administer drugs through the diffusive action in the skin. Several of these patches present a slow and targeted release of the medicine into the blood stream, thus avoided the need for oral or even intramuscular administrations of the medicine. Used to treat and control symptoms of chronic diseases, to provide analgesia, hormone replacement therapy, and sedatives, smoking cessation, biologic transdermal patches are considered for their simple applicability, effectiveness, and patient compliance.
The market for Transdermal Skin Patches has expanded at a phenomenally high rate over the years mainly because of growing popularity for painless drug application. One of the main advantages of transdermal patches is maintaining the constancy of releasing drugs and it is helpful for patients who will have to use the medicine replies and unremitting, like, pain-related medicines, or hormones, etc. This market has been able to enjoy new developments in Material science, enhanced drug release profiles, and new adhesive technologies that secure better drug fix and at the same time avoid skin irritation. Developments in the area of lifestyle diseases like hypertension and arthritis, and growth in the global population, have boosted the market for these skin patches as they are more comfortable in use compared to traditional systems.
Whereas initial demand arose from pain relief and an aid to smoking cessation, more recent applications such as menopausal hormone therapy as well as the treatment of overactive bladder are increasingly popular. Extension of the market is also facilitated by government incentives targeted at managing chronic diseases and improving patient outcomes. Regulatory compliance, high cop development costs and also skin irritation effects are among the challenge’s players will have to overcome.
Transdermal Skin Patches Market Trend Analysis:
Increasing Use of Transdermal Patches for Chronic Conditions
One of the dominant strategies in the current market for medical devices for the management of chronic illnesses is the use of transdermal patches. Learned diseases such as arthritis, cardiovascular diseases and diabetes, need to be administered repeatedly and transdermal patches are effective. People receive a consistent drug release over time and not as with normal tablets where one would have to take the medicine often. Hence, patches enhance patient compliance especially among elderly patients and are less intrusive than other well-known systems.
The increase in chronic diseases that characterize modern societies has created a need for better long-term management products. Transdermal patches represent a promising trend since it eliminates the drawbacks associated with the intakes of pills, particularly in those patients with certain diseases who hardly swallow pills, or those patients who have difficultly remembering number of medications. Recent development in polymer sciences substantiates this trend, as the patches are becoming increasingly safe and efficacious in terms of chronic treatment applications.
Expansion in Emerging Markets
Transdermal Skin Patches Market is expected to find a promising opportunity in the emerging markets. Chronic diseases are on the increase in Asia-Pacific and South America because of changes in demography such as aging and lifestyles. Since patients from these areas are diagnosed with diseases such as diabetes and cardiovascular diseases, there is a need to look for other treatments that are more convenient to administer and release slowly in the body.
Healthcare in countries with emerging markets has stepped up through the efforts of governments to enhance base and people’s understanding of high-quality care. There is an increasing population of patients that could benefit from the convenience of the transdermal patches. Manufacturers can produce new economic patches disclosing potential demands and preferences of these regions, as well as the development of the healthcare systems.
Transdermal Skin Patches Market Segment Analysis:
Transdermal Skin Patches Market is Segmented on the basis of Type, Application, Distribution Channel and Region.
By Type, Single Layer Drug in Adhesive segment is expected to dominate the market during the forecast period
The market based on the type can be divided into Single Layer Drug in Adhesive, Multiple Layer Drug in Adhesive, Matrix and others. Both kinds are utilizing different characteristics depending upon application and requirements for drug release. Single layer drug in adhesive systems are common because they are easy and inexpensive to manufacture. These patches are less complex with respect to shapes, as the drug is incorporated into the adhesive layer and can be directly applied to the skin in a steady controlled manner.
While single-layer drug-in-adhesive patches offer limited options for elaborate drug release methods, multiple-layer drug-in-adhesive patches are applicable in multiple drug releasing systems required by multiple drug formulation and applications that require controlled release. Matrix patches are generalized patches in which the drug is incorporated in a polymer matrix and the rate of release is constant, and well suited for chronic disorders. The kind of diversity enables one to counter different facets of patients as well as their states flexibly.
By Application, Pain Relief segment expected to held the largest share
Transdermal skin patches have uses such as, analgesia, smoking cessation or reduction, overactive bladder, hormone replacement, and others. Another primary use is pain relief, including such diseases as arthritis when a patch will provide steady pain relief as opposed to an injection. These patches give the patients’ comfort without the high and low of oral medication, thus enhancing their lives.
Smoking cessation patches are also standard in the market and have high popularity among people. These patches produce a fixed amount of nicotine and often minimize the dependence of a person in smoking. Other advanced markets include hormonal therapy patches and others related to over-activity bladder, which present a great opportunity for growth. There are even hormone therapy patches, where the hormone consistently flows into the body of the patient throughout the designated period which is very helpful, especially for conditions such as menopause where people need to be very steady with the hormones in their system.
Transdermal Skin Patches Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
North America is the largest market in the Transdermal Skin Patches Market now and talking about the future and its position in this market, it can be said that all conditions are created for further growth in this region a developed healthcare system, active development of research in the field of new medicines and products, and the recognition and demand for the name of the patient. Health care organization in the region are favorable to the development of new drug delivery technologies and regulations governing the manufacturing of the patch are favorable to enhancing the efficacy and safety of the patch patching technologies through access to advanced research instruments.
There is high incidence of chronic diseases and increasing population with the age factors in North America, which lead to higher acceptance of transdermal patches. The region’s focus on making patients more convenient and following treatment has a connection to the market since healthcare practitioners are continuing to support non-pharmacological approaches to enhance patient outcome and quality of care.
Active Key Players in the Transdermal Skin Patches Market
3M Company (USA)
Abbott Laboratories (USA)
Bayer AG (Germany)
Boehringer Ingelheim (Germany)
GlaxoSmithKline plc (UK)
Hisamitsu Pharmaceutical Co., Inc. (Japan)
Johnson & Johnson (USA)
Mylan N.V. (USA)
Novartis AG (Switzerland)
Purdue Pharma (USA)
Sanofi (France)
Teva Pharmaceutical Industries Ltd. (Israel)
Other Active Players.
Key Industry Developments in the Transdermal Skin Patches Market:
In September 2023, Corium, LLC, a biopharmaceutical company, published data confirming the success of its donepezil transdermal system, ADLARITY, in a placebo-controlled trial with healthy volunteers. It is the first U.S. FDA-approved donepezil transdermal system for patients with mild, moderate, and severe Alzheimer’s dementia.
In September 2023, Zydus Lifesciences Ltd announced the final approval from the U.S. Food and Drug Administration (USFDA) for its Norelgestromin and Ethinyl Estradiol Transdermal System. This skin patch delivers a combination hormone medication designed to prevent pregnancy effectively.
In August 2023, Yaral Pharma, the U.S. generics subsidiary of IBSA, introduced the Lidocaine Patch 5%, positioned as an AB-rated equivalent to Lidoderm. This prescription-strength lidocaine patch is a significant addition to Yaral Pharma’s lineup of non-opioid prescription products designed to alleviate pain and inflammation effectively.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter’s Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Transdermal Skin Patches Market by Type
4.1 Transdermal Skin Patches Market Snapshot and Growth Engine
4.2 Transdermal Skin Patches Market Overview
4.3 Single Layer Drug in Adhesive
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Single Layer Drug in Adhesive: Geographic Segmentation Analysis
4.4 Multiple layer Drug in Adhesive
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Multiple layer Drug in Adhesive: Geographic Segmentation Analysis
4.5 Matrix
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Matrix: Geographic Segmentation Analysis
4.6 Others
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Others: Geographic Segmentation Analysis
Chapter 5: Transdermal Skin Patches Market by Application
5.1 Transdermal Skin Patches Market Snapshot and Growth Engine
5.2 Transdermal Skin Patches Market Overview
5.3 Pain Relief
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Pain Relief: Geographic Segmentation Analysis
5.4 Smoking Reduction and Cessation Aid
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Smoking Reduction and Cessation Aid: Geographic Segmentation Analysis
5.5 Overactive Bladder
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Overactive Bladder: Geographic Segmentation Analysis
5.6 Hormonal Therapy
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Hormonal Therapy: Geographic Segmentation Analysis
5.7 Other)
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Other): Geographic Segmentation Analysis
5.8 Distribution Channel(Hospital Pharmacies
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Distribution Channel(Hospital Pharmacies: Geographic Segmentation Analysis
5.9 Retail Pharmacies
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Retail Pharmacies: Geographic Segmentation Analysis
5.10 Online Pharmacies)
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 Online Pharmacies) : Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Transdermal Skin Patches Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 JOHNSON & JOHNSON (USA)NOVARTIS AG (SWITZERLAND)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 MYLAN N.V. (USA)
6.4 3M COMPANY (USA)
6.5 GLAXOSMITHKLINE PLC (UK)
6.6 BAYER AG (GERMANY)
6.7 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
6.8 BOEHRINGER INGELHEIM (GERMANY)
6.9 SANOFI (FRANCE)
6.10 OTHER ACTIVE PLAYERS
Chapter 7: Global Transdermal Skin Patches Market By Region
7.1 Overview
7.2. North America Transdermal Skin Patches Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Single Layer Drug in Adhesive
7.2.4.2 Multiple layer Drug in Adhesive
7.2.4.3 Matrix
7.2.4.4 Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Pain Relief
7.2.5.2 Smoking Reduction and Cessation Aid
7.2.5.3 Overactive Bladder
7.2.5.4 Hormonal Therapy
7.2.5.5 Other)
7.2.5.6 Distribution Channel(Hospital Pharmacies
7.2.5.7 Retail Pharmacies
7.2.5.8 Online Pharmacies)
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Transdermal Skin Patches Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Single Layer Drug in Adhesive
7.3.4.2 Multiple layer Drug in Adhesive
7.3.4.3 Matrix
7.3.4.4 Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Pain Relief
7.3.5.2 Smoking Reduction and Cessation Aid
7.3.5.3 Overactive Bladder
7.3.5.4 Hormonal Therapy
7.3.5.5 Other)
7.3.5.6 Distribution Channel(Hospital Pharmacies
7.3.5.7 Retail Pharmacies
7.3.5.8 Online Pharmacies)
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Russia
7.3.6.2 Bulgaria
7.3.6.3 The Czech Republic
7.3.6.4 Hungary
7.3.6.5 Poland
7.3.6.6 Romania
7.3.6.7 Rest of Eastern Europe
7.4. Western Europe Transdermal Skin Patches Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Single Layer Drug in Adhesive
7.4.4.2 Multiple layer Drug in Adhesive
7.4.4.3 Matrix
7.4.4.4 Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Pain Relief
7.4.5.2 Smoking Reduction and Cessation Aid
7.4.5.3 Overactive Bladder
7.4.5.4 Hormonal Therapy
7.4.5.5 Other)
7.4.5.6 Distribution Channel(Hospital Pharmacies
7.4.5.7 Retail Pharmacies
7.4.5.8 Online Pharmacies)
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 The Netherlands
7.4.6.5 Italy
7.4.6.6 Spain
7.4.6.7 Rest of Western Europe
7.5. Asia Pacific Transdermal Skin Patches Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Single Layer Drug in Adhesive
7.5.4.2 Multiple layer Drug in Adhesive
7.5.4.3 Matrix
7.5.4.4 Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Pain Relief
7.5.5.2 Smoking Reduction and Cessation Aid
7.5.5.3 Overactive Bladder
7.5.5.4 Hormonal Therapy
7.5.5.5 Other)
7.5.5.6 Distribution Channel(Hospital Pharmacies
7.5.5.7 Retail Pharmacies
7.5.5.8 Online Pharmacies)
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Transdermal Skin Patches Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Single Layer Drug in Adhesive
7.6.4.2 Multiple layer Drug in Adhesive
7.6.4.3 Matrix
7.6.4.4 Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Pain Relief
7.6.5.2 Smoking Reduction and Cessation Aid
7.6.5.3 Overactive Bladder
7.6.5.4 Hormonal Therapy
7.6.5.5 Other)
7.6.5.6 Distribution Channel(Hospital Pharmacies
7.6.5.7 Retail Pharmacies
7.6.5.8 Online Pharmacies)
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkiye
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Transdermal Skin Patches Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Single Layer Drug in Adhesive
7.7.4.2 Multiple layer Drug in Adhesive
7.7.4.3 Matrix
7.7.4.4 Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Pain Relief
7.7.5.2 Smoking Reduction and Cessation Aid
7.7.5.3 Overactive Bladder
7.7.5.4 Hormonal Therapy
7.7.5.5 Other)
7.7.5.6 Distribution Channel(Hospital Pharmacies
7.7.5.7 Retail Pharmacies
7.7.5.8 Online Pharmacies)
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Q1: What would be the forecast period in the Transdermal Skin Patches Market research report?
A1: The forecast period in the Transdermal Skin Patches Market research report is 2024-2032.
Q2: Who are the key players in the Transdermal Skin Patches Market?
A2: Johnson & Johnson (USA)Novartis AG (Switzerland), Mylan N.V. (USA),3M Company (USA), GlaxoSmithKline plc (UK), Bayer AG (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Boehringer Ingelheim (Germany), Sanofi (France), and Other Active Players
Q3: What are the segments of the Transdermal Skin Patches Market?
A3: The Transdermal Skin Patches Market is segmented into Type, Application, Distribution Channel and region. By Type, the market is categorized into Single Layer Drug in Adhesive, Multiple layer Drug in Adhesive, Matrix, Others. By Application, the market is categorized into Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy, Other. By Distribution Channel, the market is categorized into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Russia, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
Q4: What is the Transdermal Skin Patches Market?
A4: The Transdermal Skin Patches Market is centred on the processes of invention and supply of stickers that are stuck on the skin to administer drugs through the diffusive action in the skin. Several of these patches present a slow and targeted release of the medicine into the blood stream, thus avoided the need for oral or even intramuscular administrations of the medicine. Used to treat and control symptoms of chronic diseases, to provide analgesia, hormone replacement therapy, and sedatives, smoking cessation, biologic transdermal patches are considered for their simple applicability, effectiveness, and patient compliance.
Q5: How big is the Transdermal Skin Patches Market?
A5: Transdermal Skin Patches Market Size Was Valued at USD 7.89 Billion in 2023, and is Projected to Reach USD 12.35 Billion by 2032, Growing at a CAGR of 5.1% From 2024-2032.
How to Buy a Report from eminsights.jp
On the product page, choose the license you want: Single-User License, Multi-User License or Enterprise License.
If you required report in your native language, then you can click on Translated Report button and fill out the form with report name and language you want, then our team will contact you as soon as possible.
Click the Buy Now button.
You will be redirected to the checkout page. Enter your company details and payment information.
Click Place Order to complete the purchase.
Confirmation: You’ll receive an order confirmation and our team will contact you shortly with your ordered report.
If you have any questions, fill out the contact form below or email us at bizdev@eminsights.net.
Thank you for choosing eminsights.jp!
